Hasnain Jafferbhoy

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Nicholas A. Kennedy, Graham Heap, Harry Green et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 677 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

Aleksejs Sazonovs, Nicholas A. Kennedy, Loukas Moutsianas et al. · Gastroenterology · 2019 · 409 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study

Neil Chanchlani, Simeng Lin, Claire Bewshea et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 123 citations · Full text

Medicine, Clinical Sciences, Immunology +17

Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort

Nikolas Plevris, Cher Shiong Chuah, Rhiannon Allen et al. · Journal of Crohn s and Colitis · 2019 · 51 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Real‐world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort

Nikolas Plevris, James Fulforth, Spyros I. Siakavellas et al. · Journal of Gastroenterology and Hepatology · 2020 · 40 citations

Veterinary Medicine, Clinical Sciences, Pharmacotherapy +16